神经酰胺-1-磷酸对环磷酰胺诱导的早发性卵巢功能不全小鼠模型卵巢损伤具有保护作用
该研究在6-8周龄小鼠中观察卵巢囊内注射神经酰胺-1-磷酸(C1P)对环磷酰胺(Cy)所致卵巢损伤的保护作用。结果显示C1P可恢复卵泡储备和激素水平、抑制凋亡、改善基质血管并保护生育力与卵母细胞质量;作者认为C1P可能是有前景的生育力保存策略,但结果来自体内动物模型,需进一步研究。
要点
- Cy使小鼠原始、初级和窦前卵泡减少、闭锁卵泡增加,C1P两种剂量均使这些卵泡结构恢复至对照水平。
- Cy升高血清FSH并降低卵巢E2,C1P可阻止FSH升高并使E2恢复至对照水平。
- Cy降低妊娠率并减小窝仔数,C1P联合处理可维持正常生育力。
核心结论
- 局部给予C1P可通过保护卵泡储备、恢复激素水平、抑制凋亡和改善基质血管,大幅减少Cy诱导的小鼠卵巢损伤,同时保护生育力、卵母细胞质量和子宫形态。
- 作者认为,在Cy之前给予C1P可能成为接受化疗的女性患者有前景的生育力保存策略。
研究设计与样本
- 6-8周龄小鼠接受单次腹腔注射Cy(75 mg/kg)或等体积生理盐水(对照),对照与Cy组行假手术并于卵巢囊内注射生理盐水,Cy+C1P组在Cy给药前1 h于双侧卵巢囊内注射5 μl C1P(0.5或1 mM)。
- 术后2周处死动物采集血、卵巢和子宫样本;卵巢用于Western blotting、免疫组化或组织学分析或类固醇提取(每组n=5-8)。
- 一组小鼠(每组n=3)用于卵母细胞回收和IVF,另一组(每组n=5-6)用于研究生育参数。
主要发现
- Cy处理小鼠较对照动物原始卵泡(P<0.01)、初级卵泡(P<0.05)和窦前卵泡(P<0.05)数量减少,闭锁卵泡增加(P<0.001);Cy+C1P小鼠在两种C1P剂量下这些卵泡结构均恢复至对照数量。
- Cy影响AMH表达,联合给予C1P时至少部分恢复;Cy使血清FSH浓度升高(P<0.01),C1P联合给药可阻止该升高(P<0.01)。
- Cy处理卵巢E2水平较对照卵巢显著降低(P<0.01),C1P使E2水平恢复至对照卵巢水平(P<0.01)。
- Cy较对照卵巢增加BAX表达(P<0.01)并降低BCLX-L表达(P<0.01),Cy处理小鼠卵巢BCLX-L:BAX比值亦较低(P<0.05);Cy+C1P组BAX、BCLX-L表达及BCLX-L:BAX比值与对照卵巢无差异。
- Cy处理卵巢A-SMase表达较高,Cy+C1P组与对照相似;Cy较对照卵巢增加窦前和早期窦卵泡的凋亡指数(TUNEL阳性卵泡/总卵泡)(分别为P<0.001和P<0.01),C1P保护卵泡免于该增加。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 本研究结果来自体内动物实验模型,该模型已被多位作者使用。
- 需要对C1P在女性生殖中于化疗诱导卵巢衰竭等病理条件下的功能以及该鞘脂使用的安全性进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is ceramide-1-phosphate (C1P) an ovarian protective agent during alkylating chemotherapy? SUMMARY ANSWER: Local administration of C1P drastically reduces ovarian damage induced by cyclophosphamide (Cy) via protection of follicular reserve, restoration of hormone levels, inhibition of apoptosis and improvement of stromal vasculature, while protecting fertility, oocyte quality and uterine morphology. WHAT IS KNOWN ALREADY: Cancer-directed therapies cause accelerated loss of ovarian reserve and lead to premature ovarian failure (POF). Previous studies have demonstrated that C1P regulates different cellular processes including cell proliferation, cell migration, angiogenesis and apoptosis. This sphingolipid may be capable of modulating vascular development and apoptosis in ovaries affected by chemotherapy. STUDY DESIGN, SIZE, DURATION: The 6-8-week-old mice were weighed and administered either a single intraperitoneal injection of Cy (75 mg/kg) or an equal volume of saline solution only for control mice. Control and Cy mice underwent sham surgery and received an intrabursal injection of saline solution, while Cy + C1P animal groups received 5 μl C1P, either 0.5 or 1 mM, under the bursa of both ovaries 1 h prior to Cy administration. PARTICIPANTS/MATERIALS, SETTING, METHODS: Animals were euthanized by cervical dislocation or cardiac puncture 2 weeks after surgery for collection of blood orovary and uterus samples, which were cleaned of adhering tissue in culture medium and used for subsequent assays. Ovaries were used for Western blotting or immunohistochemical and/or histological analyses or steroid extraction, as required (n = 5-8 per group). A set of mice (n = 3/group) was destined for oocyte recovery and IVF. Finally, another set (n = 5-6/group) was separated to study fertility parameters. MAIN RESULTS AND THE ROLE OF CHANCE: The number of primordial (P < 0.01), primary (P < 0.05) and preantral follicles (P < 0.05) were decreased in Cy-treated mice compared to control animals, while atretic follicles were increased (P < 0.001). In Cy + C1P mice, the ovaries recovered control numbers of these follicular structures, in both C1P doses studied. Cy affected AMH expression, while it was at least partially recovered when C1P is administered as well. Cy caused an increase in serum FSH concentration (P < 0.01), which was prevented by C1P coadministration (P < 0.01). E2 levels in Cy-treated ovaries decreased significantly compared to control ovaries (P < 0.01), whilst C1P restored E2 levels to those of control ovaries (P < 0.01). Cy increased the expression of BAX (P < 0.01) and decreased the expression of BCLX-L compared to control ovaries (P < 0.01). The ovarian BCLX-L:BAX ratio was also lower in Cy-treated mice (P < 0.05). In the Cy + C1P group, the expression levels of BAX, BCLX-L and BCLX-L:BAX ratio were no different than those in control ovaries. In addition, acid sphingomyelinase (A-SMase) expression was higher in Cy-treated ovaries, whilst remaining similar to the control in the Cy + C1P group. Cy increased the apoptotic index (TUNEL-positive follicles/total follicles) in preantral and early antral stages, compared to control ovaries (P < 0.001 and P < 0.01, respectively). C1P protected follicles from this increase. No primordial or primary follicular cells stained for either cleaved caspase-3 or TUNEL when exposed to Cy, therefore, we have found no evidence for follicular reserve depletion in response to Cy being due to apoptosis. Cy caused evident vascular injury, especially in large cortical stromal vessels, and some neovascularization. In the Cy + C1P group, the disruptions in vascular wall continuity were less evident and the number of healthy stromal blood vessels seemed to be restored. In Cy-treated ovaries α-SMA-positive cells showed a less uniform distribution around blood vessels. C1P coadministration partially prevented this Cy-induced effect, with a higher presence of α-SMA-positive cells surrounding vessels. By H&E staining, Cy-treated mice showed endometrial alterations compared to controls, affecting both epithelial and stromal compartments. However, C1P allowed that the stromal tissue to maintain its loose quality and its glandular branches. Cy-treated animals had significantly lower pregnancy rates and smaller litter sizes compared with control mice (P = 0.013 and P < 0.05, respectively), whereas cotreatment with C1P preserved normal fertility. Furthermore, a higher (P < 0.05) proportion of abnormal oocytes was recovered from Cy-treated mice compared to the control, which was prevented by C1P administration. LARGE SCALE DATA: N/A. LIMITATIONS REASONS FOR CAUTION: The results of this study were generated from an in-vivo animal experimental model, already used by several authors. Further studies on C1P functions in female reproduction in pathological conditions such as chemotherapy-induced ovarian failure and on the safety of use of this sphingolipid are required. WIDER IMPLICATIONS OF THE FINDINGS: The present findings showed that C1P administration prior to Cy might be a promising fertility preservation strategy in female patients who undergo chemotherapy. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by grants from ANPCyT (PICT 2015-1117), CONICET (PIP 380), Cancer National Institute (INC) and Roemmers Foundation, Argentina. The authors declare no conflicts of interest.
引用
- Pascuali N, Scotti L, Di Pietro M, et al. Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure. Hum Reprod. 2018. PMID: 29534229. doi:10.1093/humrep/dey045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。